Results 1 to 10 of about 398,610 (305)

Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models. [PDF]

, 2014
The aim of the present study was to examine the efficacy of tumor-targeting Salmonella typhimurium A1-R treatment following anti-vascular endothelial growth factor (VEGF) therapy on VEGF-positive human pancreatic cancer.
Bouvet, Michael, Chishima, Takashi, Endo, Itaru, Hiroshima, Yukihiko, Hoffman, Robert M, Ichikawa, Yasushi, Maawy, Ali, Matsuyama, Ryusei, Miwa, Shinji, Momiyama, Masashi, Mori, Ryutaro, Murakami, Takashi, Sato, Sho, Tanaka, Kuniya, Yamamoto, Mako, Yano, Shuya, Zhang, Yong, Zhao, Ming   +17 more
core   +16 more sources

Microfluidic-Assisted Human Cancer Cells Culturing Platform for Space Biology Applications

Sensors, 2022
In the paper, the lab-on-chip platform applicable for the long-term cultivation of human cancer cells, as a solution meeting the demands of the CubeSat biological missions, is presented.
Agnieszka Krakos (Podwin), Joanna Jarosz, Patrycja Śniadek, Mateusz Psurski, Adrianna Graja, Marcin Białas, Ewa Oliszewska, Joanna Wietrzyk, Rafał Walczak, Jan Dziuban   +9 more
doaj   +1 more source

Combined Therapy with microRNA-Expressing Salmonella and Irradiation in Melanoma

Microorganisms, 2021
Anticancer treatment strategies using bacteria as a vector are currently expanding with the development of anticancer drugs. Here, we present a research strategy to develop anticancer drugs using bacteria that contain miRNAs.
Wonsuck Yoon, Yongsung Park, Seunghyun Kim, Yongkeun Park, Chul Yong Kim   +4 more
doaj   +1 more source

Circulation of Fluorescently Labelled Phage in a Murine Model

Viruses, 2021
Interactions between bacteriophages and mammals strongly affect possible applications of bacteriophages. This has created a need for tools that facilitate studies of phage circulation and deposition in tissues.
Zuzanna Kaźmierczak, Joanna Majewska, Magdalena Milczarek, Barbara Owczarek, Krystyna Dąbrowska   +4 more
doaj   +1 more source

Use of Anticancer Therapies and Economic Burden Near the End of Life in Japan: Results From Claims Database

JCO Global Oncology, 2022
PURPOSEIn patients with cancer, aggressive treatment near the end of life (EOL) may decrease quality of life and increase medical costs. In this study, we examined the use of anticancer therapies near the EOL in Japan.METHODSWe used a commercial database
Yusuke Kajimoto, Kazunori Honda, Kazuki Nozawa, Mineko Mukai, Lida Teng, Ataru Igarashi   +5 more
doaj   +1 more source

Three-Component Reaction of Diamines with Triethyl Orthoformate and Diethyl Phosphite and Anti-Proliferative and Antiosteoporotic Activities of the Products

Molecules, 2020
A three-component reaction between diamines (diaminobenzenes, diaminocyclohexanes, and piperazines), triethyl orthoformate, and diethyl phosphite was studied in some detail.
Patrycja Petruczynik, Paweł Kafarski, Mateusz Psurski, Joanna Wietrzyk, Zdzisław Kiełbowicz, Jan Kuryszko, Ewa Chmielewska   +6 more
doaj   +1 more source

Prediction of Anticancer Peptides Using a Low-Dimensional Feature Model

Frontiers in Bioengineering and Biotechnology, 2020
Cancer is still a severe health problem globally. The therapy of cancer traditionally involves the use of radiotherapy or anticancer drugs to kill cancer cells, but these methods are quite expensive and have side effects, which will cause great harm to ...
Qingwen Li, Wenyang Zhou, Donghua Wang, Sui Wang, Sui Wang, Qingyuan Li   +5 more
doaj   +1 more source

Guidance letter for cardiologists and primary care physicians on primary prevention of cardiovascular complications of anticancer therapy. Interdisciplinary Council of Cardio-Oncology, Russian Society of Cardiology

Кардиоваскулярная терапия и профилактика, 2023
.
Yu. A. Vasyuk, G. E. Gendlin, E. I. Emelina, I. G. Nikitin, V. I. Potievskaya, E. Yu. Shupenina   +5 more
doaj   +1 more source

Eurasian clinical guidelines for cardiovascular complications of cancer treatments: diagnosis, prevention and treatment (2022)

Евразийский Кардиологический Журнал, 2022
Disclaimer. The EAC Guidelines represent the views of the EAC, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication.
I. E. Chazova, F. T. Ageev, A. V. Aksenova, M. V. Vicenya, M. Yu. Gilyarov, T. V. Martynyuk, E. P. Panchenko, M. G. Poltavskaya, V. I. Potievskaya, O. P. Trofimova, Yu. A. Fedotkina   +10 more
doaj   +1 more source

Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1 [PDF]

, 2020
Cancer therapeutics: Extending a drug's reach A new drug that blocks heat shock proteins (HSPs), helper proteins that are co-opted by cancer cells to promote tumor growth, shows promise for cancer treatment.
Chae, Young Chan, Hong, Jun-Hee, Hu, Sung, Kang, Byoung Heon, Kim, So Yeon, Lee, Ji-Eun, Nam, Dougu, Park, Hye-Kyung, Park, Jong Bae, Yoon, Nam Gu, Yoon, Sora   +10 more
core   +1 more source